![John Yee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Yee
Director/Board Member at
TEMPEST THERAPEUTICS, INC.
Profile
John David Yee is currently Director at Comera Life Sciences, Inc., Director at Tempest Therapeutics, Inc. starting in 2026, and Senior Vice President-Medical Affairs at Apnimed, Inc. since 2023.
Former roles include Independent Director at Comera Life Sciences Holdings, Inc. from 2022 to 2023, Senior VP & Head-Medical Affairs at Vertex Pharmaceuticals, Inc. from 2017 to 2019, Vice President & Head-Medical Affairs at Genzyme Corp.
from 2003 to 2011, Senior Vice President-Medical Affairs at Flexion Therapeutics, Inc. from 2019 to 2020, Vice President-Global Medical Affairs at Intarcia Therapeutics, Inc. from 2016 to 2017, and Chief Medical Officer at Sobi, Inc. from 2020 to 2023.
Education includes a doctorate from Harvard Medical School, graduate studies at Harvard T.H.
Chan School of Public Health, and undergraduate studies at Harvard College.
John Yee active positions
| Companies | Position | Start |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director/Board Member | 2026-06-03 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Director/Board Member | - |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Former positions of John Yee
| Companies | Position | End |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Director/Board Member | 2023-01-02 |
Sobi, Inc.
 Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| FLEXION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Training of John Yee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Health Technology |
Sobi, Inc.
Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Distribution Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- John Yee
